Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-037611
Filing Date
2025-02-27
Accepted
2025-02-27 07:30:37
Documents
16
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d885219ds8.htm S-8 35030
2 EX-5.1 d885219dex51.htm EX-5.1 6435
3 EX-23.2 d885219dex232.htm EX-23.2 1582
4 EX-FILING FEES d885219dexfilingfees.htm   iXBRL EX-FILING FEES 40143
5 GRAPHIC g885219g0226102739575.jpg GRAPHIC 2661
  Complete submission text file 0001193125-25-037611.txt   247643

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d885219dexfilingfees_htm.xml XML 18922
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285306 | Film No.: 25673024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)